AbbVie (NYSE:ABBV) Lowered to Buy Rating by StockNews.com
AbbVie (NYSE:ABBV – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday. Other equities analysts also recently issued research reports about the stock. Guggenheim raised their target price on shares of AbbVie from $212.00 to $214.00 and gave the […]
AbbVie (NYSE:ABBV – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday. Other equities analysts also recently issued research reports about the stock. Guggenheim raised their target price on shares of AbbVie from $212.00 to $214.00 and gave the […]
